Ameritas Investment Partners, Inc. Seres Therapeutics, Inc. Transaction History

Ameritas Investment Partners, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$4.67 - $6.55 $12,029 - $16,872	2,576 Added 47.21%	8,033 $38,000
Q2 2021 Aug 06, 2021	BUY	$18.46 - $24.36 $17,223 - $22,727	933 Added 20.62%	5,457 $130,000
Q3 2020 Nov 13, 2020	BUY	$3.74 - $28.74 $4,933 - $37,908	1,319 Added 41.15%	4,524 $128,000
Q4 2019 Feb 13, 2020	BUY	$2.99 - $4.42 $5,429 - $8,026	1,816 Added 130.74%	3,205 $11,000
Q2 2017 Aug 15, 2017	BUY	N/A	1,389	1,389 $16,000

46.3M

119K

466K

Ticker MCRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,072,000
Market Cap $114M
Description
Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...

Get notified when there are updates to the investment portfolio of Ameritas Investment Partners, Inc., based on Form 13F filings with the SEC.

Stay updated on Ameritas Investment Partners, Inc. with notifications on news.